Description
| MitraClip™ TEER Therapy
MitraClip™ Transcatheter Edge-to-Edge Repair (TEER) procedure is a minimally invasive treatment option, uniquely designed for the mitral valve, for select patients with primary or secondary MR. As the first TEER therapy recommended by ACC/AHA1 and ESC/EACTS2-3 guidelines and by ASPC Recommendation,4 MitraClip is the standard of care in TMVr built on the only proven mitral valve therapy with over 20+ years of experience, extensive body of clinical evidence, and more than 200,000 patients treated worldwide,5 allowing physicians to treat more patients with more options. |
 |
| Navitor™ TAVI System
Advancing the forefront of innovative design, the Navitor™ Transcatheter Aortic Valve Implantation (TAVI) System brings together stable delivery, remarkable performance, and a future-ready design. |
 |
| TriClip™ TEER System
TriClip™ Transcatheter Edge-to-Edge Repair (TEER) is a non-surgical treatment option for patients with symptomatic severe Tricuspid Regurgitation (TR), despite optimal medical therapy. TriClip TEER offers exceptional safety7,8 and maximized effectiveness8,9 to significantly improve quality of life (QoL) and functional status of patients with TR. |
 |
